Dallas P. Seitz, MD; Andrea Gruneir, PhD; Paula A. Rochon, MD, MPH
Seitz DP, Gruneir A, Rochon PA. Second-generation antipsychotics did not improve outcomes and increased costs for patients with Alzheimer disease and psychosis. ACP J Club. 2008;148:53. doi: 10.7326/ACPJC-2008-148-2-053
Download citation file:
Published: ACP J Club 2008;148(2):53.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use